Disease Info Card

Malignant Germ Cell Tumor

Information about Malignant Germ Cell Tumor: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Malignant Germ Cell Tumor

Most recent studies have shown that Malignant Germ Cell Tumor shares some biological mechanisms with carcinoma, carcinoma-in-situ, cryptorchidism, dysgerminoma, embryonal-carcinoma, germ-cell-tumor, germinoma, malignant-neoplasm-of-testis, malignant-neoplasms, malignant-paraganglionic-neoplasm, mediastinal-neoplasms, neoplasm-metastasis, neoplasm-recurrence-local, neoplasms, neoplasms-germ-cell-and-embryonal, ovarian-neoplasm, seminoma, teratoma, testicular-neoplasms, yolk-sac-tumor.

Among the many pathways, these few ones have gauged particular interests from scientists studying Malignant Germ Cell Tumor, and have been seen in publications frequently: Cell Cycle, Cell Development, Cell Differentiation, Cell Proliferation, Dna Methylation, Dna Repair, Drug Resistance, Enucleation, Fertilization, Germ Cell Development, Germ Cell Proliferation, Glomerular Filtration, Induction Of Apoptosis, Localization, Meiosis, Methylation, Pathogenesis, Sex Determination, Spermatogenesis, Translation

Quite a number of genes have been found to play important roles in Malignant Germ Cell Tumor, such as AFP, AR, BRD2, CGA, CSF3, ESR1, ESR2, FDXR, FGF4, KITLG, MID1, PGR, PLOD1, POU5F1, TP53, TRIM26, VIP. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.